Skip to main content
Caplight Logo









RevitalVision

RevitalVision

Private
IsraelHealthcare & Life Scienceshttps://www.revitalvision.com/

Last Round

Grant

Aug 19, 2024

Total Funding Raised

$1.75M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RevitalVision is a healthtech company that provides a SaaS-based digital training therapy technology designed for vision improvement.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

vision therapydigital therapeuticsamblyopia treatmentlazy eye treatmentneuroplasticityFDA clearedat-home vision therapyDTxperceptual learningpresbyopia treatmentvisual processingAI vision therapypost-LASIK vision improvementpost-cataract vision improvementCPT codessports vision trainingGabor patches

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RevitalVision Comparables

Compare RevitalVision with similar companies based on industry and business-model similarity.

RevitalVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CureSee
85%
Vivid Vision
85%
Hundred Vision
85%

RevitalVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 19, 2024
StrategicJan 1, 2024
AcceleratorNov 1, 2022
CrowdfundingMay 31, 2021
GrantAug 14, 2020

Key People

Founding team and executive leadership

Yair Yahav

Chief Executive Officer

Executive Team

RevitalVision Investors

Notable investors and investment history

RevitalVision investors
InvestorRounds
Israel Innovation AuthorityGrant
MATTERGrant
PipelBizCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 238% MoM, reaching 29.8K.

  • Mar 2, 2026

    Monthly visitors increased 36% MoM, reaching 11.2K.

RevitalVision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RevitalVision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RevitalVision's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range16
Year Founded2019
Last FundingAug 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?